cja haasbeek
cja haasbeek
radiotherapeut, VUMC Amsterdam
Verified email at vumc.nl - Homepage
Title
Cited by
Cited by
Year
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
JY Chang, S Senan, MA Paul, RJ Mehran, AV Louie, P Balter, HJM Groen, ...
The Lancet Oncology 16 (6), 630-637, 2015
10872015
Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non–small-cell lung cancer
FJ Lagerwaard, CJA Haasbeek, EF Smit, BJ Slotman, S Senan
International Journal of Radiation Oncology* Biology* Physics 70 (3), 685-692, 2008
5582008
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
DA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ...
The Lancet 393 (10185), 2051-2058, 2019
5552019
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis
S Senthi, FJ Lagerwaard, CJA Haasbeek, BJ Slotman, S Senan
The lancet oncology 13 (8), 802-809, 2012
4012012
Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer
FJ Lagerwaard, NE Verstegen, CJA Haasbeek, BJ Slotman, MA Paul, ...
International Journal of Radiation Oncology* Biology* Physics 83 (1), 348-353, 2012
3532012
Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a …
NE Verstegen, JWA Oosterhuis, DA Palma, G Rodrigues, FJ Lagerwaard, ...
Annals of oncology 24 (6), 1543-1548, 2013
2762013
Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer
CJA Haasbeek, FJ Lagerwaard, BJ Slotman, S Senan
Journal of Thoracic Oncology 6 (12), 2036-2043, 2011
2312011
Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review
S Senthi, CJA Haasbeek, BJ Slotman, S Senan
Radiotherapy and Oncology 106 (3), 276-282, 2013
2212013
Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review
D Palma, F Lagerwaard, G Rodrigues, C Haasbeek, S Senan
International Journal of Radiation Oncology* Biology* Physics 82 (3), 1149-1156, 2012
1992012
Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review
D Palma, F Lagerwaard, G Rodrigues, C Haasbeek, S Senan
International Journal of Radiation Oncology* Biology* Physics 82 (3), 1149-1156, 2012
1992012
Stage I nonsmall cell lung cancer in patients aged≥ 75 years: outcomes after stereotactic radiotherapy
CJA Haasbeek, FJ Lagerwaard, ME Antonisse, BJ Slotman, S Senan
Cancer: Interdisciplinary International Journal of the American Cancer …, 2010
1842010
Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands
CJA Haasbeek, D Palma, O Visser, FJ Lagerwaard, B Slotman, S Senan
Annals of oncology 23 (10), 2743-2747, 2012
1522012
Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial
DA Palma, CJA Haasbeek, GB Rodrigues, M Dahele, M Lock, B Yaremko, ...
BMC cancer 12 (1), 1-8, 2012
1402012
Whole-brain radiotherapy with simultaneous integrated boost to multiple brain metastases using volumetric modulated arc therapy
FJ Lagerwaard, EAP Van Der Hoorn, WFAR Verbakel, CJA Haasbeek, ...
International Journal of Radiation Oncology* Biology* Physics 75 (1), 253-259, 2009
1312009
Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence
FWA Hoefnagels, FJ Lagerwaard, E Sanchez, CJA Haasbeek, DL Knol, ...
Journal of neurology 256 (6), 878-887, 2009
1312009
Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease
NE Verstegen, FJ Lagerwaard, CJA Haasbeek, BJ Slotman, S Senan
Radiotherapy and Oncology 101 (2), 250-254, 2011
1222011
Patient-reported quality of life after stereotactic ablative radiotherapy for early-stage lung cancer
FJ Lagerwaard, NK Aaronson, CM Gundy, CJA Haasbeek, BJ Slotman, ...
Journal of Thoracic Oncology 7 (7), 1148-1154, 2012
1122012
Stereotactic ablative radiation therapy for the comprehensive treatment of oligometastatic tumors (SABR-COMET): results of a randomized trial
DA Palma, RA Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, ...
International Journal of Radiation Oncology, Biology, Physics 102 (3), S3-S4, 2018
992018
Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer
EM Bongers, CJA Haasbeek, FJ Lagerwaard, BJ Slotman, S Senan
Journal of Thoracic Oncology 6 (12), 2052-2057, 2011
982011
Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer
SA Mattonen, DA Palma, CJA Haasbeek, S Senan, AD Ward
Medical physics 41 (3), 033502, 2014
952014
The system can't perform the operation now. Try again later.
Articles 1–20